A possible therapeutic target for control of blood glucose in the treatment of type 2 diabetes and obesity has been identified by researchers. In a nutrient-rich environment typical of the developed world today, carbohydrate-rich diets and positive feedback to glucagon signaling increases gluconeogenesis leading to chronic hyperglycemia, obesity, and insulin resistance.